|
|
Blood, 1 October 2004, Vol. 104, No. 7, pp. 2176-2177.
Prepublished online as a Blood First Edition Paper on May 11, 2004; DOI 10.1182/blood-2004-01-0400.
Previous Article | Next Article 
Submitted February 3, 2004
Accepted April 13, 2004
Identification of a novel mutation (C321X) in HJV
Franklin W Huang, Isabel Rubio-Aliaga, James P Kushner, Nancy C Andrews, and Mark D Fleming*
Division of Medical Sciences, Harvard University, Boston, MA, USA; Pediatrics, Children's Hospital and Harvard Medical School, Boston, MA, USA
Pediatrics, Children's Hospital and Harvard Medical School, Boston, MA, USA; Howard Hughes Medical Institute, Boston, MA, USA
Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA
Pediatrics, Children's Hospital and Harvard Medical School, Boston, MA, USA; Howard Hughes Medical Institute, Boston, MA, USA; Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA, USA
Division of Medical Sciences, Harvard University, Boston, MA, USA; Pathology, Children's Hospital and Harvard Medical School, Boston, MA, USA
* Corresponding author; email: mark.fleming{at}childrens.harvard.edu.
Juvenile hemochromatosis is a rare autosomal recessive disorder characterized by the early onset of severe iron overload. Recently, mutations causing juvenile hemochromatosis have been identified in a novel gene, hemojuvelin (HJV). We report the occurrence of compound heterozygous mutations in HJV, including a termination codon, in a patient with juvenile hemochromatosis, but no prior family history of iron disorders.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Hemojuvelin and hepcidin: the keys to JH?
- Eric Nisbet-Brown
Blood 2004 104: 1918-1919.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
L. Silvestri, A. Pagani, C. Fazi, G. Gerardi, S. Levi, P. Arosio, and C. Camaschella
Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis
Blood,
May 15, 2007;
109(10):
4503 - 4510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Donovan, C. N. Roy, and N. C. Andrews
The Ins and Outs of Iron Homeostasis
Physiology,
April 1, 2006;
21(2):
115 - 123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Camaschella
Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders
Blood,
December 1, 2005;
106(12):
3710 - 3717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-S. Zhang, A. P. West Jr., A. E. Wyman, P. J. Bjorkman, and C. A. Enns
Interaction of Hemojuvelin with Neogenin Results in Iron Accumulation in Human Embryonic Kidney 293 Cells
J. Biol. Chem.,
October 7, 2005;
280(40):
33885 - 33894.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Janosi, H. Andrikovics, K. Vas, A. Bors, M. Hubay, Z. Sapi, and A. Tordai
Homozygosity for a novel nonsense mutation (G66X) of the HJV gene causes severe juvenile hemochromatosis with fatal cardiomyopathy
Blood,
January 1, 2005;
105(1):
432 - 432.
[Full Text]
[PDF]
|
 |
|
|
|